Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

1.0K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.0K
Cognitive Therapy01:25

Cognitive Therapy

1.4K
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Better together - efficacy of combined physical and cognitive training in young adults for enhancing physical and cognitive performance: a randomized controlled trial.

Frontiers in sports and active living·2026
Same author

A randomised controlled trial of physical activity and cognitive training in older adults: the PhABHeaD study.

Trials·2026
Same author

Disordered eating in elite youth athletes: A scoping review of studies published since 2000.

JSAMS plus·2026
Same author

Establishing guiding principles for a music-making intervention for healthy brain ageing.

Arts & health·2026
Same author

'The players are the focus, it's never spoken about as coaches': Perceived factors influencing the mental health of Australian elite-level coaches.

Psychology of sport and exercise·2026
Same author

Microscopic white matter changes in the cingulum contribute to memory impairment among older adults with obstructive sleep apnea in the memory clinic.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Related Experiment Video

Updated: Mar 11, 2026

Author Spotlight: Rehabilitation of Stroke Patients With a Digital Occupational Training System
07:35

Author Spotlight: Rehabilitation of Stroke Patients With a Digital Occupational Training System

Published on: December 29, 2023

2.2K

Cognitive Training in Parkinson's Disease.

Courtney C Walton1,2,3, Sharon L Naismith1,2, Amit Lampit3

  • 11 Parkinson's Disease Research Clinic, Brain and Mind Centre, University of Sydney, NSW, Australia.

Neurorehabilitation and Neural Repair
|December 1, 2016
PubMed
Summary

Cognitive training (CT) offers a promising non-pharmacological approach for Parkinson's disease (PD) patients experiencing cognitive impairment. Further research into CT as a PD intervention is crucial for improving patient well-being.

Keywords:
Parkinson’s diseasecognitive impairmentcognitive rehabilitationcognitive trainingdementia

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.4K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.4K

Related Experiment Videos

Last Updated: Mar 11, 2026

Author Spotlight: Rehabilitation of Stroke Patients With a Digital Occupational Training System
07:35

Author Spotlight: Rehabilitation of Stroke Patients With a Digital Occupational Training System

Published on: December 29, 2023

2.2K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.4K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.4K

Area of Science:

  • Neuroscience
  • Neurology
  • Cognitive Psychology

Background:

  • Cognitive impairment is a core feature of Parkinson's disease (PD).
  • Existing pharmacological treatments for PD often involve polypharmacy, limiting options.
  • Non-pharmacological interventions are needed to address cognitive decline in PD.

Purpose of the Study:

  • To review the efficacy of cognitive training (CT) in Parkinson's disease (PD) populations.
  • To highlight CT as a potential non-invasive behavioral intervention for PD-related cognitive impairment.
  • To advocate for prioritizing research into CT for PD.

Main Methods:

  • Literature review of existing studies on cognitive training.
  • Analysis of CT efficacy in diverse populations and specifically in PD samples.
  • Discussion of current research gaps and future directions for CT in PD.

Main Results:

  • Cognitive training (CT) has demonstrated benefits across various populations.
  • Emerging evidence suggests CT is effective for cognitive impairment in Parkinson's disease (PD).
  • CT is a well-tolerated and non-invasive intervention.

Conclusions:

  • Cognitive training (CT) shows significant potential as a therapeutic option for cognitive impairment in Parkinson's disease (PD).
  • Further research is warranted to establish CT as a standard intervention for PD.
  • CT should be considered a research priority for improving quality of life in PD patients.